Replies to post #69009 on Biotech Values

[DewDiligence]

IDIX Major Shareholders

[Updated for shares issued to GSK in the IDX899 partnership.
The denominator used for the percentages shown below is 59.1M,
the number of common shares outstanding today rather than the
63M fully-diluted figure I use for valuation purposes (#msg-37350098).
JP Sommadossi owns 1.8M options plus the 2.2.M shares shown below.]

 
                        Shares  Stake 
 Novartis            31,309.498 53.0% 
 MPM Capital          3,243,306  5.5% 
 GlaxoSmithKline      2,474,527  4.2% 
 JP Sommadossi (CEO)  2,219,754  3.8%